GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Short-Term Capital Lease Obligation

Peptron (XKRX:087010) Short-Term Capital Lease Obligation : ₩108 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Peptron Short-Term Capital Lease Obligation?

Peptron's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩108 Mil.

Peptron's quarterly Short-Term Capital Lease Obligation increased from Mar. 2024 (₩41 Mil) to Jun. 2024 (₩91 Mil) and increased from Jun. 2024 (₩91 Mil) to Sep. 2024 (₩108 Mil).

Peptron's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩55 Mil) to Dec. 2022 (₩95 Mil) but then declined from Dec. 2022 (₩95 Mil) to Dec. 2023 (₩58 Mil).

Peptron Short-Term Capital Lease Obligation Historical Data

The historical data trend for Peptron's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron Short-Term Capital Lease Obligation Chart

Peptron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.63 97.05 54.65 94.95 57.89

Peptron Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.42 57.89 40.82 90.74 107.59

Peptron Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Peptron Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Peptron's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Peptron Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XKRX:950210 XKRX:950160 XKRX:005250 XKRX:310210 XKRX:182400 XKRX:052020 XKRX:215600 XKRX:298380 XKRX:358570 XKRX:005690 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811
Website
http://www.peptron.com
Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron Headlines

No Headlines